Fertility and Infertility Research News Portal

DUBLIN, Feb. 19, 2021 /PRNewswire/ -- The "Women's Health Diagnostics Market by Application (Biopsy, Cervical & Ovarian Cancer Testing, PAP Smear, HPV, TORCH, Prenatal Testing, Hepatitis, Ultrasound, Obstetrics), End User (Hospitals, Clinics, Home Care), COVID-19 Impact - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The Women's Health Diagnostics Market is Projected to Reach USD 36.6 Billion by 2025 from USD 25.0 Billion in 2020, at a CAGR of 7.9%

In the past decade, the demand for various health diagnostic tests has increased significantly across the globe. Currently, the market is mainly driven by growing awareness about various health-related disorders, rising incidence of chronic and lifestyle disorders, and the high prevalence of infectious diseases such as HIV and hepatitis in women across the globe.

The increasing adoption of POC diagnostic testing and the growth in the number of diagnostic and imaging centers are also expected to support the growth of this market during the forecast period. However, the high cost of diagnostic devices, tests, and procedures; shortage of skilled laboratory technicians; and insufficient reimbursements for diagnostic tests are expected to restrain this market's growth to a certain extent.

Based on application, the breast cancer testing segment holds the largest market share during the forecast period.

Based on application, the women's health diagnostics market is divided into nine segments-osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing, and ultrasound tests. The breast cancer testing segment accounted for the larger market share in 2019. The large share of this segment can be attributed to the increasing incidence of breast cancer and rising awareness about advanced breast cancer diagnostic techniques, such as ABUS.

Based on end-user, the home care settings segment is expected to register the highest CAGR during the forecast period.

Based on end users, the women's health diagnostics market is segmented into hospitals & clinics, diagnostic & imaging centers, and home care settings. The home care settings segment is expected to witness the highest growth during the forecast period. The increasing advantages of using self-testing kits will continue to drive market growth. Patient self-testing enables patients to better manage their diseases by utilizing home/self-testing kits. Technological advancements have made many self-testing kits available for various conditions, such as pregnancy and ovulation.

North America is expected to account for the largest share of the women's health diagnostics market in 2019

In 2019, North America accounted for the largest share of the women's health diagnostics market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The large share of this market segment can be attributed to the increasing prevalence of cancer among women, the growing focus of manufacturers of women's health diagnostic products on expanding their presence in this region, and the increasing demand for fertility testing monitors. In addition, the rising acceptance of POC diagnostics and PST practices is also expected to drive the growth of this regional segment during the forecast period.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights4.1 Women's Health Diagnostics Market Overview4.2 APAC: Pregnancy & Fertility Testing Market, by Type (2019)4.3 Geographic Snapshot of the Women's Health Diagnostics Market4.4 Geographic Mix: Women's Health Diagnostics Market

5 Market Overview5.1 Introduction5.2 Market Dynamics5.2.1 Market Drivers5.2.1.1 High Prevalence of Infectious Diseases in Women5.2.1.2 Rising Incidence of Chronic and Lifestyle-Related Disorders in Women5.2.1.3 Increasing Awareness About Fertility Testing in Women and Initiatives by Government and Health Organizations5.2.1.4 Increased Adoption of Poc and Rapid Diagnostic Tests5.2.1.5 Growth in the Number of Private Diagnostic and Imaging Centers5.2.1.6 Public-Private Partnerships Are Expected to Enhance Infrastructure in Diagnostic Imaging Centers5.2.2 Market Restraints5.2.2.1 High Cost of Diagnostic Imaging Systems and Procedures5.2.2.2 Shortage of Skilled Laboratory Technicians5.2.3 Market Opportunities5.2.3.1 Improving Healthcare Infrastructure in Emerging Markets5.2.3.2 Growing Number of Regulatory Approvals for Immunoassay Diagnostic Techniques5.2.4 Market Challenges5.2.4.1 Stringent Regulatory Guidelines5.2.4.2 Increasing Adoption of Refurbished Diagnostic Imaging Systems5.3 COVID-19 Impact on the Women's Health Diagnostics Market

6 Women's Health Diagnostics Market, by Application6.1 Introduction6.2 Breast Cancer Testing6.3 Infectious Disease Testing6.4 Cervical Cancer Testing6.5 Std Testing6.6 Osteoporosis Testing6.7 Prenatal Genetic Screening & Carrier Testing6.8 Pregnancy & Fertility Testing6.9 Ultrasound Tests6.10 OVC Testing

7 Women's Health Diagnostics Market, by End-user7.1 Introduction7.2 COVID-19 Impact on the Women's Health Diagnostics Market, by End-user7.3 Hospitals & Clinics7.4 Diagnostic & Imaging Centers7.5 Home Care Settings

8 Women's Health Diagnostics Market, by Region

9 Competitive Landscape9.1 Overview9.2 Geographical Assessment of the Major Players in the Women's Health Diagnostics Market9.3 Revenue Share Analysis of Top Players9.4 Market Share Analysis9.5 Competitive Leadership Mapping9.5.1 Stars9.5.2 Emerging Leaders9.5.3 Pervasive Players9.5.4 Emerging Companies9.6 Competitive Leadership Mapping for Start-Ups9.6.1 Progressive Companies9.6.2 Dynamic Companies9.6.3 Starting Blocks9.6.4 Responsive Companies9.7 Competitive Situation and Trends9.7.1 Product Launches & Enhancements9.7.2 Expansions9.7.3 Acquisitions9.7.4 Other Strategies

10 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/za8eu

Media Contact:

Research and Markets Laura Wood, Senior Manager [emailprotected]

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

http://www.researchandmarkets.com

Visit link:
Global Women's Health Diagnostics Market Report 2021-2025: Home Care Segment is Expected to Register the Highest Growth - PRNewswire